Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin

Comparison of pHH3, Ki-67, and Survivin Immunoreactivity in Benign and Malignant Melanocytic Lesions

(2009) Michel R Nasr et al.   AMERICAN JOURNAL OF DERMATOPATHOLOGY

Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability

(2009) C. A. Pise-Masison et al.   BLOOD

Phase I Study of YM155, a Novel Survivin Suppressant, in Patients with Advanced Solid Tumors

(2009) T. Satoh et al.   CLINICAL CANCER RESEARCH

Caspases and inhibitor of apoptosis proteins in cutaneous and mucosal melanoma: expression profile and clinicopathologic significance

(2009) Ni Chen et al.   HUMAN PATHOLOGY

Expression of the Antiapoptosis Gene Survivin Predicts Poor Prognosis of Stage III Gastric Adenocarcinoma

(2009) K. Y. Song et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Multicenter Phase II Trial of YM155, a Small-Molecule Suppressor of Survivin, in Patients With Advanced, Refractory, Non–Small-Cell Lung Cancer

(2009) Giuseppe Giaccone et al.   JOURNAL OF CLINICAL ONCOLOGY

Survivin expression in primary malignant melanoma of the esophagus

(2009) Satoshi Mamori et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Gambogic acid, a potent inhibitor of survivin, reverses docetaxel resistance in gastric cancer cells

(2008) Tingting Wang et al.   CANCER LETTERS

Radiosensitizing Effect of YM155, a Novel Small-Molecule Survivin Suppressant, in Non-Small Cell Lung Cancer Cell Lines

(2008) T. Iwasa et al.   CLINICAL CANCER RESEARCH

Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics

(2008) A. C. Mita et al.   CLINICAL CANCER RESEARCH

Phase I and Pharmacokinetic Study of YM155, a Small-Molecule Inhibitor of Survivin

(2008) Anthony W. Tolcher et al.   JOURNAL OF CLINICAL ONCOLOGY

Chemically synthesized human survivin does not inhibit caspase-3

(2008) Changqing Li et al.   PROTEIN SCIENCE